Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

OptimizeRx (OPRX) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for OptimizeRx (OPRX) over the last 17 years, with Q3 2025 value amounting to $0.04.

  • OptimizeRx's EPS (Basic) rose 10800.0% to $0.04 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.26, marking a year-over-year increase of 11940.37%. This contributed to the annual value of -$1.1 for FY2024, which is 673.12% down from last year.
  • Per OptimizeRx's latest filing, its EPS (Basic) stood at $0.04 for Q3 2025, which was up 10800.0% from $0.08 recorded in Q2 2025.
  • In the past 5 years, OptimizeRx's EPS (Basic) ranged from a high of $0.26 in Q4 2024 and a low of -$0.5 during Q3 2024
  • Over the past 5 years, OptimizeRx's median EPS (Basic) value was -$0.17 (recorded in 2023), while the average stood at -$0.13.
  • Its EPS (Basic) has fluctuated over the past 5 years, first tumbled by 850095.19% in 2022, then skyrocketed by 20746.41% in 2024.
  • Quarter analysis of 5 years shows OptimizeRx's EPS (Basic) stood at $0.04 in 2021, then plummeted by 150.63% to -$0.02 in 2022, then plummeted by 1209.91% to -$0.24 in 2023, then soared by 207.46% to $0.26 in 2024, then tumbled by 84.49% to $0.04 in 2025.
  • Its last three reported values are $0.04 in Q3 2025, $0.08 for Q2 2025, and -$0.12 during Q1 2025.